ITRM920535A0 - Composizione farmaceutica per la somministrazione attraverso le mucose. - Google Patents

Composizione farmaceutica per la somministrazione attraverso le mucose.

Info

Publication number: ITRM920535A0
Authority: IT; Italy
Prior art keywords: mucosa; administration; pharmaceutical composition; pharmaceutical; composition
Prior art date: 1991-07-15

Application number

IT92RM535A

Other languages

English (en)

Inventor

Gerd Fricker

Jacky Vonderscher

Moise Azria

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-15

Filing date

1992-07-14

Publication date

1992-07-14

1991-07-15 Priority claimed from GB919115202A external-priority patent/GB9115202D0/en

1992-01-14 Priority claimed from GB929200748A external-priority patent/GB9200748D0/en

1992-07-14 Application filed by Sandoz Ag filed Critical Sandoz Ag

1992-07-14 Publication of ITRM920535A0 publication Critical patent/ITRM920535A0/it

1994-01-14 Publication of ITRM920535A1 publication Critical patent/ITRM920535A1/it

1996-08-05 Application granted granted Critical

1996-08-05 Publication of IT1263222B publication Critical patent/IT1263222B/it

Links

210000004877 mucosa Anatomy 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Rheumatology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

ITRM920535A 1991-07-15 1992-07-14 Composizione farmaceutica per la somministrazione attraverso le mucose. IT1263222B (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB919115202A GB9115202D0 (en)	1991-07-15	1991-07-15	Improvements relating to organic compounds
GB929200748A GB9200748D0 (en)	1992-01-14	1992-01-14	Improvements relating to organic compounds

Publications (3)

Publication Number	Publication Date
ITRM920535A0 true ITRM920535A0 (it)	1992-07-14
ITRM920535A1 ITRM920535A1 (it)	1994-01-14
IT1263222B IT1263222B (it)	1996-08-05

Family

ID=26299234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ITRM920535A IT1263222B (it)	1991-07-15	1992-07-14	Composizione farmaceutica per la somministrazione attraverso le mucose.

Country Status (7)

Country	Link
JP (1)	JPH05194260A (it)
BE (1)	BE1007752A5 (it)
CH (1)	CH685600A5 (it)
DE (1)	DE4222647A1 (it)
FR (1)	FR2682598B1 (it)
GB (1)	GB2257908B (it)
IT (1)	IT1263222B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5698521A (en) *	1995-04-04	1997-12-16	Zymogenetics, Inc.	Native calcitonin mimetics
US5698672A (en) *	1995-04-04	1997-12-16	Zymogenetics, Inc.	Synthetic calcitonin mimetics
AU1808897A (en) *	1995-12-13	1997-07-03	Dullatur Limited	A calcitonin preparation
GB9614235D0 (en) *	1996-07-06	1996-09-04	Danbiosyst Uk	Composition for enhanced uptake of polar drugs from mucosal surfaces
CA2288968A1 (en)	1997-04-14	1998-10-22	Takashi Yazaki	Permucous preparation
US7030082B2 (en) *	2001-09-07	2006-04-18	Nobex Corporation	Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4151276A (en) *	1975-05-12	1979-04-24	Armour Pharmaceutical Company	Method of suppressing gastric acid secretion by the oral administration of calcitonin
GB2127689B (en) *	1982-10-05	1986-07-09	Sandoz Ltd	Calcitonin inhalation compositions
IL70489A0 (en) *	1982-12-29	1984-03-30	Armour Pharma	Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
JPS61194034A (ja) *	1985-02-25	1986-08-28	Teijin Ltd	経鼻投与用粉末状組成物
HU203204B (en) *	1987-09-15	1991-06-28	Sandoz Ag	Process for producing suppository containing calcitonin and taurocholic acid
DK163689A (da) *	1988-04-08	1989-10-30	Sandoz Ag	Peptidderivater
HU206367B (en) *	1988-04-30	1992-10-28	Sandoz Ag	Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
JP2911496B2 (ja) *	1989-09-11	1999-06-23	帝國製薬株式会社	生理活性ポリペプチド含有高吸収性経膣剤
EP0432431B1 (en) *	1989-11-16	1993-06-16	PHIDEA S.p.A.	Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient

1992
- 1992-07-10 DE DE4222647A patent/DE4222647A1/de not_active Withdrawn
- 1992-07-13 CH CH2194/92A patent/CH685600A5/de not_active IP Right Cessation
- 1992-07-13 BE BE9200650A patent/BE1007752A5/fr not_active IP Right Cessation
- 1992-07-13 FR FR9208675A patent/FR2682598B1/fr not_active Expired - Fee Related
- 1992-07-13 GB GB9214830A patent/GB2257908B/en not_active Expired - Fee Related
- 1992-07-14 JP JP4186621A patent/JPH05194260A/ja active Pending
- 1992-07-14 IT ITRM920535A patent/IT1263222B/it active IP Right Grant

Also Published As

Publication number	Publication date
FR2682598A1 (fr)	1993-04-23
IT1263222B (it)	1996-08-05
DE4222647A1 (de)	1993-01-21
ITRM920535A1 (it)	1994-01-14
GB2257908B (en)	1995-12-20
BE1007752A5 (fr)	1995-10-17
FR2682598B1 (fr)	1996-04-05
CH685600A5 (de)	1995-08-31
GB9214830D0 (en)	1992-08-26
GB2257908A (en)	1993-01-27
JPH05194260A (ja)	1993-08-03

Legal Events

Date	Code	Title	Description
1996-08-05	0001	Granted
1999-10-27	TA	Fee payment date (situation as of event date), data collected since 19931001	Effective date: 19960927

Publication	Publication Date	Title
DE69101931D1 (de)	1994-06-16	Pharmazeutische Zusammensetzung.
DE3863963D1 (de)	1991-09-05	Pharmazeutische zusammensetzungen.
ITRM910696A1 (it)	1993-03-18	Composizioni farmaceutiche per l'applicazione per via nasale.
ITBO910024A1 (it)	1992-07-30	Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
DE68901417D1 (de)	1992-06-11	Pharmazeutische zusammensetzung.
ATA129892A (de)	1997-07-15	Pharmazeutische zusammensetzung
ATE71837T1 (de)	1992-02-15	Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE3868986D1 (de)	1992-04-16	Pharmazeutische zusammensetzungen.
FI921060A0 (fi)	1992-03-11	Farmaceutiska aerosolformuleringar.
FI922252A0 (fi)	1992-05-18	Farmaceutisk sammansaettning.
FI922316A0 (fi)	1992-05-21	Farmaceutisk sammansaettning.
FI951901L (fi)	1995-04-21	Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
DE69115263D1 (de)	1996-01-18	Pharmazeutische zusammensetzungen.
ATE203400T1 (de)	2001-08-15	Pharmazeutische formulierungen
DE4291156T1 (de)	1994-10-20	Verbesserte pharmazeutische Zusammensetzungen
FI923581A0 (fi)	1992-08-11	Farmaceutisk kombinationsformation.
DE3485408D1 (de)	1992-02-13	Pharmazeutische zusammensetzung.
FI950947L (fi)	1995-09-03	Oraalisesti annettavat farmaseuttiset formulaatiot
DE69006094D1 (de)	1994-03-03	Pharmazeutische Zusammensetzungen.
IT1212778B (it)	1989-11-30	Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
DE3682083D1 (de)	1991-11-28	Pharmazeutische zusammensetzungen.
DZ1559A1 (fr)	2002-02-17	Compositions pharmaceutiques.
FI910088L (fi)	1991-07-10	Oral farmaceutisk komposition.
DE3674040D1 (de)	1990-10-18	Pharmazeutische zusammensetzungen.
MX9200532A (es)	1992-08-01	Agente farmaceuticos.